The retail sector delivered a mixed performance during the festive season, with select pockets emerging as bright spots, ...

Dr Reddy’s share price rose nearly 4% after Nuvama Institutional Equities upgraded its rating to ’Buy’ with a target of ...

Dr. Reddys Laboratories shares rose 4% after Nuvama upgraded its rating to 'buy,' citing proactive strategies to mitigate the ...

Zypp Electric is in advanced talks to raise $25-30 million from investors led by Nuvama Wealth. Tribe Capital is ...

The surge in Dr. Reddy's share followed an upgrade by domestic brokerage Nuvama, which raised its rating on the stock to 'Buy ...

JM Financial forecasts Jio’s ARPU to rise 4.5% QoQ to ₹204. Bharti Airtel is expected to see 4.8% QoQ growth in India ...

Nuvama assigned a target price of Rs 1,553 per share on Dr. Reddy's stock, implying an upside of 14.8% from the previous ...

Nomura, on January 6, upgraded SBI Card share to ‘Buy’ from ‘Reduce’ on rising share of top metro cities in its new card ...

Niftys earnings per share (EPS) expected by a modest 2 per cent year-on-year (YoY) in the third quarter of FY25, according to ...

India’s economy is navigating a phase of subdued demand as growth in key sectors slows down. Multiple dynamics impact exports ...

Media companies expected to report muted Q3FY25 results with some segments showing growth, but overall performance remains ...

A long-term investor mindset will help make money, focus on new products at pharma companies draws to a close, Meta’s latest shift befuddles Indian fact-checkers, and more ...